Literature DB >> 28764273

Prevalence of Metabolic Syndrome among Psychiatric Inpatients: A Hospital Based Study from Kashmir.

Tajamul Hussain1, Mushtaq Ahmad Margoob2, Sheikh Shoib1, Mahak Shafat3, Rajesh Kumar Chandel4.   

Abstract

INTRODUCTION: Over the last fifty years there has been dramatic change in the human environment, behaviours and way-of-life. These changes have resulted in escalating rates of metabolic syndrome not only in general population but also among people with mental illness. Various factors, like the lack of exercise, use of psychotropic medications and inadequate medical care leads to the increased risk of metabolic changes among people with mental illness. Hence, there is a greater need to evaluate metabolic syndrome in this population. AIM: To find the prevalence of metabolic syndrome among psychiatric inpatients in Tertiary Care Hospital in Kashmir region of North India.
MATERIALS AND METHODS: It was a cross-sectional study conducted at the Institute of Mental Health and Neurosciences, Kashmir, India. A total of 213 in-patients with a primary psychiatric diagnosis as per The International Classification of Diseases, Tenth Revision (ICD 10) Classification of Mental and Behavioural Disorders criteria were evaluated for the presence of metabolic syndrome. A modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criterion for the diagnosis of metabolic syndrome was used. All the intergroup comparisons for parametric data were done by Student's t-test, whereas non-parametric data were analysed by Chi-square tests. A p-value <0.05 was considered statistically significant.
RESULTS: The overall prevalence of metabolic syndrome was 34.74%. The prevalence was higher in females (43.3%) than males (28.5%) (p<0.05) and it increased with age, with the highest prevalence in the age group >50 years (p<0.05). Among the diagnostic subgroups, the prevalence was highest among patients with unipolar depression (45.0%), while it was lesser in patients with bipolar disorders (37.88%) and psychotic disorders (30.95%). Prevalence of metabolic syndrome was significantly higher (63.64%) among patients taking second generation antipsychotics (p<0.05).
CONCLUSION: Our study shows that metabolic syndrome is highly prevalent among psychiatric inpatients and needs to be addressed to prevent the risk for cardiovascular diseases.

Entities:  

Keywords:  Dyslipidemia; Insulin resistance; Mental illness; Obesity

Year:  2017        PMID: 28764273      PMCID: PMC5535463          DOI: 10.7860/JCDR/2017/25801.10011

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  36 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Atypical antipsychotics related metabolic syndrome in bipolar patients.

Authors:  Mehmet Yumru; Haluk A Savas; Erhan Kurt; M Cemal Kaya; Salih Selek; Esen Savas; E Timucin Oral; Ilhan Atagun
Journal:  J Affect Disord       Date:  2006-09-12       Impact factor: 4.839

3.  Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Authors:  Christoph U Correll; Anne M Frederickson; John M Kane; Peter Manu
Journal:  Schizophr Res       Date:  2006-10-27       Impact factor: 4.939

4.  Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.

Authors:  Abhishek Pallava; Rakesh K Chadda; Mamta Sood; R Lakshmy
Journal:  Nord J Psychiatry       Date:  2011-10-24       Impact factor: 2.202

5.  Metabolic issues in schizophrenic patients receiving antipsychotic treatment.

Authors:  Aditi Gupta; Gora Dadheech; Dharamveer Yadav; Praveen Sharma; Shiv Gautam
Journal:  Indian J Clin Biochem       Date:  2014-01-23

Review 6.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

7.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

8.  Metabolic syndrome in patients with schizophrenia.

Authors:  Tuula Heiskanen; Leo Niskanen; Riitta Lyytikäinen; Pirjo I Saarinen; Jukka Hintikka
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

9.  Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study.

Authors:  Fuminari Misawa; Keiko Shimizu; Yasuo Fujii; Ryouji Miyata; Fumio Koshiishi; Mihoko Kobayashi; Hirokazu Shida; Yoshiyo Oguchi; Yasuyuki Okumura; Hiroto Ito; Mami Kayama; Haruo Kashima
Journal:  BMC Psychiatry       Date:  2011-07-26       Impact factor: 3.630

10.  The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong--a cross sectional study.

Authors:  Daniel T Bressington; Jolene Mui; Eric F C Cheung; Joel Petch; Allan B Clark; Richard Gray
Journal:  BMC Psychiatry       Date:  2013-03-18       Impact factor: 3.630

View more
  5 in total

1.  Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication.

Authors:  Maria S Simon; Barbara Barton; Anja Zagler; Katharina Engl; Leonora Rihs; Catherine Glocker; Richard Musil
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-01       Impact factor: 5.270

2.  Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia.

Authors:  Tesfaye Teshome; Dejene Hailu Kassa; Agete Tadewos Hirigo
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-27       Impact factor: 3.168

3.  Anxiety behavior and hypothalamic-pituitary-adrenal axis altered in a female rat model of vertical sleeve gastrectomy.

Authors:  Alexandra R Himel; Sharon A Cabral; James P Shaffery; Bernadette E Grayson
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

4.  Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda.

Authors:  David Collins Agaba; Richard Migisha; Rosemary Namayanja; Godfrey Katamba; Henry Mark Lugobe; Hillary Aheisibwe; Godfrey Twesigomwe; Scholastic Ashaba
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

5.  Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia.

Authors:  Aleksandra Koricanac; Aleksandra Tomic Lucic; Mirjana Veselinovic; Danijela Bazic Sretenovic; Gorica Bucic; Anja Azanjac; Olivera Radmanovic; Mirjana Matovic; Marijana Stanojevic; Aleksandra Jurisic Skevin; Bojana Simovic Markovic; Jelena Pantic; Nebojša Arsenijevic; Gordana D Radosavljevic; Maja Nikolic; Nenad Zornic; Jelena Nesic; Nemanja Muric; Branimir Radmanovic
Journal:  Front Psychiatry       Date:  2022-07-25       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.